Physician

Anthony J Griess, MD

According to 2025 Medicare claims, Anthony Griess, MD (NPI: 1598713935) practices dermatology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is DERMATOLOGY SPECIALISTS OF OMAHA LLC (NPI: 1457551889; TIN: 26-0309843) and primary practice location at 68114-2508.

Griess' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 1,606 HCPCS/CPT codes, and received $516,378 in Medicare payments. The top billing code was 17313 (Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks). Part D data shows 68 prescription claims across 52 beneficiaries totaling $1,038 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 6 records totaling $95. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $19,564 to $1,038. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$353K$705K2015 Medicare payment: $635,297 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $662,713 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $635,410 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $705,312 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $657,892 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $538,426 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $575,531 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $569,704 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $620,070 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $516,378 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157403,533$635,297
20167673,529$662,713
20177473,200$635,410
20187842,956$705,312
20196482,296$657,892
20205201,766$538,426
20215601,873$575,531
20225571,898$569,704
20236192,035$620,070
20244961,606$516,378

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.8K$20K2015 Drug cost: $19,564 (USD; Tot_Drug_Cst)2016 Drug cost: $8,737 (USD; Tot_Drug_Cst)2017 Drug cost: $7,011 (USD; Tot_Drug_Cst)2018 Drug cost: $7,678 (USD; Tot_Drug_Cst)2019 Drug cost: $3,780 (USD; Tot_Drug_Cst)2020 Drug cost: $2,347 (USD; Tot_Drug_Cst)2021 Drug cost: $2,166 (USD; Tot_Drug_Cst)2022 Drug cost: $1,669 (USD; Tot_Drug_Cst)2023 Drug cost: $2,475 (USD; Tot_Drug_Cst)2024 Drug cost: $1,038 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015119228$19,564
2016129212$8,737
2017106166$7,011
201896159$7,678
201972108$3,780
202077110$2,347
2021120158$2,166
202298147$1,669
2023125162$2,475
20245268$1,038

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks6393$446
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks390461$442
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks201311$318
13121Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm7997$185
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm152165$181

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MupirocinMupirocin12194$87

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$95MIMEDX Group, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anthony J. Griess, MD?

Tedicare shows public-source Medicare data for Anthony J. Griess, MD (NPI 1598713935), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony J. Griess, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony J. Griess, MD?

Anthony J. Griess, MD is linked to DERMATOLOGY SPECIALISTS OF OMAHA LLC (billing NPI 1457551889) in the available physician profile data.

Does Anthony J. Griess, MD have Open Payments data?

Anthony J. Griess, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.